|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.52 CNY | -1.51% |
|
-2.59% | +3.50% |
| Capitalization | 8.07B 1.17B 985M 898M 858M 1.59B 106B 1.65B 10.45B 4.15B 51.12B 4.38B 4.29B 179B | P/E ratio 2025 * |
10.3x | P/E ratio 2026 * | 6.8x |
|---|---|---|---|---|---|
| Enterprise value | 8.07B 1.17B 985M 898M 858M 1.59B 106B 1.65B 10.45B 4.15B 51.12B 4.38B 4.29B 179B | EV / Sales 2025 * |
3.71x | EV / Sales 2026 * | - |
| Free-Float |
22.45% | Yield 2025 * |
0.97% | Yield 2026 * | - |
| 1 day | -1.51% | ||
| 1 week | -2.59% | ||
| Current month | -3.79% | ||
| 1 month | -4.73% | ||
| 3 months | -16.30% | ||
| 6 months | -19.14% | ||
| Current year | +3.50% |
| 1 week | 19.51 |  | 20.27 |
| 1 month | 19.51 | | 21.6 |
| Current year | 18.85 | | 21.6 |
| 1 year | 18.83 | | 26.3 |
| 3 years | 18.83 | | 71.79 |
| 5 years | 18.83 | | 135.88 |
| 10 years | 18.83 | | 135.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Kong
CEO | Chief Executive Officer | 61 | 2003-12-31 |
Zhao Feng Meng
DFI | Director of Finance/CFO | 62 | 2019-01-31 |
Chang Lin Zhu
CTO | Chief Tech/Sci/R&D Officer | 58 | 2003-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Feng Li
BRD | Director/Board Member | 57 | 2004-02-29 |
Xing Gong Zhu
BRD | Director/Board Member | 59 | 2021-08-02 |
De Shen Zhang
BRD | Director/Board Member | 62 | 2019-02-20 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.51% | -2.59% | -16.26% | -70.42% | 1.17B | |
| +1.91% | +5.23% | -6.68% | -31.51% | 65.94B | |
| +3.28% | -2.20% | +35.54% | +61.79% | 9.34B | |
| +4.73% | +12.01% | +27.75% | -10.75% | 9.22B | |
| -3.70% | +0.65% | -12.92% | +62.02% | 5.93B | |
| -0.55% | +3.82% | -13.38% | +118.43% | 5.6B | |
| +2.43% | +0.64% | +243.06% | +47.11% | 4.32B | |
| -2.42% | +4.53% | +414.34% | +1,003.26% | 3.06B | |
| -2.59% | -2.84% | -11.81% | -28.58% | 2.79B | |
| +1.99% | -1.57% | +28.61% | +28.90% | 2.92B | |
| Average | +0.36% | +0.82% | +68.82% | +118.03% | 11.03B | |
| Weighted average by Cap. | +1.59% | +3.86% | +21.25% | +23.80% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.18B 315M 266M 242M 231M 429M 28.54B 446M 2.82B 1.12B 13.78B 1.18B 1.16B 48.17B | - |
| Net income | 941M 136M 115M 105M 99.91M 185M 12.33B 193M 1.22B 483M 5.96B 511M 500M 20.82B | 1.19B 172M 145M 132M 126M 234M 15.54B 243M 1.53B 609M 7.51B 644M 630M 26.23B |
| Net Debt | - | - |
Employees
1,274
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-13 | 19.52 ¥ | -1.51% | 1,735,350 |
| 26-02-12 | 19.82 ¥ | -0.75% | 1,555,473 |
| 26-02-11 | 19.97 ¥ | -0.60% | 1,361,172 |
| 26-02-10 | 20.09 ¥ | -0.05% | 1,762,579 |
| 26-02-09 | 20.10 ¥ | +0.30% | 1,477,155 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.52CNY
Average target price
32.00CNY
Spread / Average Target
+63.93%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 688276 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition